ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $153,000 | +856.2% | 359,982 | +1376.1% | 0.00% | – |
| Q4 2016 | $16,000 | -81.2% | 24,387 | -10.1% | 0.00% | – |
| Q3 2016 | $85,000 | +39.3% | 27,139 | +38.6% | 0.00% | – |
| Q2 2016 | $61,000 | +1.7% | 19,582 | +18.9% | 0.00% | – |
| Q1 2016 | $60,000 | -97.5% | 16,468 | -96.9% | 0.00% | – |
| Q4 2015 | $2,432,000 | -9.6% | 524,175 | +18.7% | 0.00% | – |
| Q3 2015 | $2,690,000 | +287.6% | 441,632 | +448.2% | 0.00% | – |
| Q2 2015 | $694,000 | +601.0% | 80,567 | +263.7% | 0.00% | – |
| Q1 2015 | $99,000 | +65.0% | 22,154 | -41.7% | 0.00% | – |
| Q4 2014 | $60,000 | – | 37,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |